Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy

Dewpoint Therapeutics, a U.S.-based biotechnology innovator, has announced the successful closure of its Series D financing round. As reported by thepharmaletter, Dewpoint Therapeutics is renowned for its pioneering work in…

Continue Reading Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy